Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 145 Neoplasm Metastasis 16 Advanced Breast Cancer 9 Neoplasms 8 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Breast Cancer Metastatic 5 Prostatic Neoplasms 4 Endometrial Neoplasms 4 Recurrence 3 Hereditary Sensory and Autonomic Neuropathies 3 Lung Neoplasms 2 Hyperglycemia 2 Exanthema 2 Estrogen Receptor-positive Breast Cancer 2 Colorectal Neoplasms 2 Carcinoma, Lobular 2 Breast Neoplasms, Male 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Neoplastic Cells, Circulating 1

Interventions

palbociclib 1 exemestane 1 elacestrant 1 Tamoxifen 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ER+ Breast Cancer × Fulvestrant × Clear all

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡